Drug Labels: New Rules for Showing Where Medicine is Made
The Senate must act next: a Senate floor vote.
This bill has strong bipartisan support and has successfully moved out of the committee stage, which is where most bills fail.
Govbase has not yet run an impact analysis on this legislation.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 523.
The bill is now on the schedule for the full chamber to consider. It's in line for debate and a vote.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.
Committee on Health, Education, Labor, and Pensions. Hearings held.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Senators introduced the CLEAR LABELS Act to require prescription drug labels to identify where medication was made, following a ProPublica investigation into dangerous foreign drugmakers. The bill aims to help patients and doctors know the origins of their medications and key ingredients.
The Senate HELP Committee advanced the CLEAR LABELS Act with a 21-1 vote. The bill, led by Sens. Rick Scott and Kirsten Gillibrand, requires drug labels to disclose original manufacturers of generic drugs and APIs to reduce reliance on foreign suppliers like China and India.
Proposed bipartisan legislation would mandate drug companies to disclose manufacturing locations for generic drugs and APIs. The bill suggests using QR codes on packaging to link to a searchable database showing manufacturing locations and drug quality scores.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
CLEAR LABELS Act
Analysis generated by AI. Always verify with official sources.